Search research articles
Contact Us
Filters
Showing results (111-120 of 663) with videos related to
Page
of 67
Sort By:
Arthritis and Rheumatism
|
December 1, 1982
Effect of metal chelators and antiinflammatory drugs on the degradation of hyaluronic acid
W H Betts, L G Cleland
Heart (British Cardiac Society)
|
April 1, 1996
Is aspirin safe in heart failure? more data
J G Cleland, P Poole-Wilson
Current Opinion in Clinical Nutrition and Metabolic Care
|
February 16, 2006
Cyclooxygenase-2 inhibitors: what went wrong?
Michael J James, Leslie G Cleland
European Journal of Heart Failure
|
December 12, 2001
Clinical trials update: highlights of the scientific sessions of the XXIII Congress of the European Society of Cardiology--WARIS II, ESCAMI, PAFAC, RITZ-1 and TIME
A P Coletta, J G Cleland
BMJ (Clinical Research Ed.)
|
August 11, 2001
Long term anticoagulation or antiplatelet treatment. Only warfarin has been shown to reduce stroke risk in patients with atrial fibrillation
J G Cleland, G C Kaye
European Heart Journal
|
April 5, 2001
How do you measure exercise capacity in chronic heart failure?
A L Clark, J G Cleland
British Journal of Rheumatology
|
May 1, 1997
Rheumatoid arthritis and the balance of dietary N-6 and N-3 essential fatty acids
L G Cleland, M J James
The American Journal of Cardiology
|
July 11, 1988
Arrhythmias, catecholamines and electrolytes
J G Cleland, H J Dargie
Investigative Ophthalmology
|
May 1, 1972
Physiology of cat retinal ganglion cells
B G Cleland, W R Levick
The Medical Journal of Australia
|
June 18, 2002
The role of fats in the lifecycle stages. Adulthood--prevention: rheumatoid arthritis
Les G Cleland, Michael J James
Page
of 67
Search research articles
Search
Showing results (111-120 of 663) with videos related to
Sort By:
Page
of 67
Arthritis and Rheumatism
|
December 1, 1982
Effect of metal chelators and antiinflammatory drugs on the degradation of hyaluronic acid
W H Betts, L G Cleland
Heart (British Cardiac Society)
|
April 1, 1996
Is aspirin safe in heart failure? more data
J G Cleland, P Poole-Wilson
Current Opinion in Clinical Nutrition and Metabolic Care
|
February 16, 2006
Cyclooxygenase-2 inhibitors: what went wrong?
Michael J James, Leslie G Cleland
European Journal of Heart Failure
|
December 12, 2001
Clinical trials update: highlights of the scientific sessions of the XXIII Congress of the European Society of Cardiology--WARIS II, ESCAMI, PAFAC, RITZ-1 and TIME
A P Coletta, J G Cleland
BMJ (Clinical Research Ed.)
|
August 11, 2001
Long term anticoagulation or antiplatelet treatment. Only warfarin has been shown to reduce stroke risk in patients with atrial fibrillation
J G Cleland, G C Kaye
European Heart Journal
|
April 5, 2001
How do you measure exercise capacity in chronic heart failure?
A L Clark, J G Cleland
British Journal of Rheumatology
|
May 1, 1997
Rheumatoid arthritis and the balance of dietary N-6 and N-3 essential fatty acids
L G Cleland, M J James
The American Journal of Cardiology
|
July 11, 1988
Arrhythmias, catecholamines and electrolytes
J G Cleland, H J Dargie
Investigative Ophthalmology
|
May 1, 1972
Physiology of cat retinal ganglion cells
B G Cleland, W R Levick
The Medical Journal of Australia
|
June 18, 2002
The role of fats in the lifecycle stages. Adulthood--prevention: rheumatoid arthritis
Les G Cleland, Michael J James
Page
of 67